Literature DB >> 4213189

Inhibition of mammalian dihydrofolate reductase by selected 2,4-diaminiquinazolines and related compounds.

W E Richter, J J McCormack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4213189     DOI： 10.1021/jm00255a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  3 in total

1.  Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study.

Authors:  N A Iscoe; E A Eisenhauer; A J Bodurtha
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

Review 2.  Clinical pharmacokinetics and pharmacology of trimetrexate.

Authors:  J L Marshall; R J DeLap
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

3.  Interpretable correlation descriptors for quantitative structure-activity relationships.

Authors:  Benson M Spowage; Craig L Bruce; Jonathan D Hirst
Journal:  J Cheminform       Date:  2009-12-24       Impact factor: 5.514
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.